When did JOUNCE THERAPEUTICS INC (JNCE) report earnings last quarter?
JOUNCE THERAPEUTICS INC (JNCE) last reported earnings on 5/10/2023.
JOUNCE THERAPEUTICS INC (JNCE) Earnings History & Surprises
NASDAQ:JNCE • US4811161011
Current stock price
1.88 USD
-0.05 (-2.59%)
At close:
1.92 USD
+0.04 (+2.13%)
After Hours:
JNCE Earnings overview
Past quarterly earnings results for JOUNCE THERAPEUTICS INC (JNCE), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Aug 2, 2023
- Period
- Q1 / 2023
- EPS Estimate
- -$0.71
- Revenue Estimate
Last Reported
Most Recent- Release Date
- May 10, 2023
- Period
- Q4 / 2022
- EPS Reported
- $0.98
- EPS Surprise
- 1,795.40%
- Revenue Surprise
- 96.08%
Beat Rate
Last 8 Quarters 0%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2022 | 0.98 | -0.06 | 1,795.40% | 266.10% | 82M | 41.82M | 96.08% | - |
| Q3 2022 | -0.60 | -0.65 | 7.85% | -1.69% | - | - | ||
| Q2 2022 | -0.65 | -0.69 | 5.77% | -712.50% | 212.497K | -100.00% | -100.00% | |
| Q1 2022 | -0.72 | -0.59 | -22.76% | -24.14% | 692.141K | -100.00% | -100.00% | |
| Q4 2021 | -0.59 | -0.32 | -82.18% | -168.60% | 12.559M | -100.00% | -100.00% | |
| Q3 2021 | -0.59 | -0.45 | -31.46% | 19.18% | 6.613M | -100.00% | - | |
| Q2 2021 | -0.08 | -0.37 | 78.21% | 90.24% | 25.368M | 8.34M | 204.17% | - |
| Q1 2021 | -0.58 | -0.42 | -38.21% | 25.64% | 1.5M | 12.043M | -87.54% | - |
| Q4 2020 | 0.86 | 0.22 | 288.29% | - | 62.3M | 40.056M | 55.53% | - |
| Q3 2020 | -0.73 | -0.48 | -50.90% | - | 3.035M | -100.00% | - | |
| Q2 2020 | -0.82 | -0.73 | -11.92% | - | - | - | ||
| Q1 2020 | -0.78 | -0.58 | -34.16% | - | 1.7M | -100.00% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
3
Average EPS beat (4)
446.56%
Max EPS beat (4)
1,795.40%
Min EPS beat (4)
-22.76%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-34.64%
Max Revenue beat (4)
96.08%
Min Revenue beat (4)
-100.00%
Analysis
In the last 4 quarters, JNCE has beaten EPS estimates in 3 out of 4 releases
JNCE has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, JNCE has beaten the EPS estimates by 446.6% on average.
In the last 4 quarters, JNCE reported -34.6% below the revenue estimates on average.
Related analysis
JOUNCE THERAPEUTICS INC / JNCE Earnings FAQ
Can you provide information on whether JOUNCE THERAPEUTICS INC beat earnings estimates in the last quarter?
JOUNCE THERAPEUTICS INC (JNCE) beat EPS estimates and beat revenue estimates in the most recent quarter.
Can you provide information on how often JOUNCE THERAPEUTICS INC beats earnings estimates?
In the last 4 quarters, JOUNCE THERAPEUTICS INC (JNCE) has beaten EPS estimates in 3 out of 4 releases.